1996

Abstract

On 28 April 1997, the EC requested consultations with India in respect of the alleged absence in India of patent protection for pharmaceutical and agricultural chemical products, and the absence of formal systems that permit the filing of patent applications of and provide exclusive marketing rights for such products. The EC contended that this is inconsistent with India’s obligations under Article 70, paragraphs 8 and 9, of the TRIPS Agreement (see similar US complaint in WT/DS50, where the Panel and Appellate Body reports were adopted on 16 January 1998).

Countries: India
Loading

Article metrics loading...

/content/reports/25189832/24
1998-08-24
2024-11-25
http://instance.metastore.ingenta.com/content/reports/25189832/24
Loading
  • Published online: 24 Aug 1998
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
aHR0cHM6Ly93d3cud3RvLWlsaWJyYXJ5Lm9yZy8K